Skip to the page

Data / Form D filings / TranspareRx Corp

TranspareRx Corp: Form D filings

TranspareRx Corp, a health care company in Naples, FL, filed 2 Form D notices with the SEC between 2020 and 2023. The latest, on June 8, 2023, reports an offering of $2.9 million with nothing sold yet.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
12250 TAMIAMI TRAIL E, Naples, FL, 34113
Phone
(855) 428-8387
Industry
Other Health Care
Entity type
Corporation
Incorporated in
Nevada
Year incorporated
2020
Revenue range
$1 - $1,000,000
Exemptions claimed
Rule 506(c)
SEC identifier (CIK)
1834462

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jun 8, 2023New notice$2,887,500$0$2,887,5000Yet to occursec.gov
Dec 3, 2020New notice$4,000,000$0$4,000,0000Yet to occursec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Charles PhillipsDirector
Neil BajajExecutive Officer
Thomas GibbonsDirector
Michael SimsDirector
Marcus OsborneDirector
Michael LoweExecutive Officer, Director
David HarrellExecutive Officer, Director
Karthik SundaramExecutive Officer

Other health care companies in Florida that filed recently

Every Form D from the week of Jun 5, 2023 · All recent filings in Florida · All recent Other Health Care filings

Read from SEC EDGAR. Amount sold is what TranspareRx Corp reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.